Health Condition 1: J00- Acute nasopharyngitis [common cold]
Conditions
Interventions
Intervention1: Clinical Study On (Iltehab e anaf hassasi) Allergic Rhinitis and its management with Unani Medicine: Each Patient will be treated for 6 weeks with Unani compound drugs (Viola odorata,Bo
Sponsors
PG Department of Moalijat General Medicine
Eligibility
Inclusion criteria
Inclusion criteria: Patients with following sign and symptoms suggesting the diagnosis of Allergic Rhinitis a. Nasal Discharge b. Sneezing c. Nasal Obstruction d. Dull Headache f. Nasal itching
Exclusion criteria
Exclusion criteria: Age 65 years were excluded from the study Pregnant women with Allergic Rhinitis Known cases of coronary artery disease, ischemic heart disease and myocardial infarction Patients with Pulmonary disease such as Allergic Bronchial Asthma and other allergic systemic disorders Deviated Nasal Septum and Sinusitis Patients with other ENT diseases were exclude
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome depends upon before and after the treatment of low Immunoglobulin E and Absolute Eosinophill Count levels within 6 weeksTimepoint: Primary outcome depends upon before and after the treatment of low Immunoglobulin E and Absolute Eosinophill Count levels within 6 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Primary outcome depends upon before and after the treatment of low Immunoglobulin E and Absolute Eosinophil Count levelsTimepoint: Primary outcome depends upon before and after the treatment of low Immunoglobulin E and Absolute Eosinophil count levels;Secondary outcome will be arelief of symptoms of allergic rhinitis after 6weeks of medicine givenTimepoint: Secondary outcome will be relief of symptoms of allergic rhinitis after 6weeks of medicine given | — |
Countries
India
Contacts
Public ContactD Aisha Khanam
Government Nizamia Tibbi college and general Hospital
Outcome results
None listed